Gastroesophageal Reflux Disease (GERD) Global Market Report 2024

Gastroesophageal Reflux Disease (GERD) Global Market Report 2024 – By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)), By Procedure (Invasive, Minimally Invasive), By End-Users (Hospital, Homecare, Specialty Clinics) – Market Size, Trends, And Global Forecast 2024-2033

Name: Gastroesophageal Reflux Disease (GERD) Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Gastroesophageal Reflux Disease (GERD) Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Gastroesophageal Reflux Disease (GERD) Market Definition

Gastroesophageal reflux disease (GERD) is a condition in which stomach acid flows back into the esophagus, causing irritation and discomfort. The treatment for the disease includes various medical strategies and interventions employed to manage the symptoms and complications associated with gastroesophageal reflux disease.

The main drug types of gastroesophageal reflux disease are antacids, proton pump inhibitors, h2 receptor blockers, pro kinetic agents, dopamine receptor antagonists, endocinch, stretta, asphyx, transoral incisionless fundoplication (TIF). Antacids are drugs that neutralize stomach acid by raising the pH level in the stomach. The various procedures include invasive and minimally invasive. These are used by various end-users such as hospitals, homecare and specialty clinics.

Gastroesophageal Reflux Disease (GERD) Market Segmentation

The gastroesophageal reflux disease (gerd) market covered in this report is segmented –

1) By Drug Type: Antacids; Proton Pump Inhibitors; H2 Receptor Blocker; Pro Kinetic Agents; Dopamine Receptor Antagonist; EndoCinch; Stretta; EsophyX; Transoral Incisionless Fundoplication (TIF)

2) By Procedure: Invasive; Minimally Invasive

3) By End-Users: Hospital; Homecare; Specialty Clinics

Global Gastroesophageal Reflux Disease GERD Market Size 2023 to 2028: Graph

Gastroesophageal Reflux Disease (GERD) Market Size 2024 And Growth Rate

The gastroesophageal reflux disease (gerd) market size has grown marginally in recent years. It will grow from $5.15 billion in 2023 to $5.25 billion in 2024 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to lifestyle and dietary changes, obesity epidemic, growing awareness about gerd treatment, globalization of pharmaceutical industry, investments for gerd treatments.

Gastroesophageal Reflux Disease (GERD) Market Growth Forecast

The gastroesophageal reflux disease (gerd) market size is expected to see steady growth in the next few years. It will grow to $5.74 billion in 2028 at a compound annual growth rate (CAGR) of 2.3%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, emergence of biomarker, growing number of screening programs for gerd, increasing prevalence of heartburn, increased demand for medical equipment. Major trends in the forecast period include diagnostic advancements, surgical advancements, development of targeted therapies, adoption of telehealth services.

Book your 30 minutes free consultation with our research experts

Gastroesophageal Reflux Disease (GERD) Market Driver: Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market

The growing prevalence of esophageal diseases is expected to propel the growth of the gastroesophageal reflux disease (GERD) market going forward. Esophageal diseases are medical conditions that affect the esophagus, a muscular tube connecting the mouth to the stomach. The treatment of esophageal diseases aims to alleviate symptoms, improve quality of life and prevent complications, ultimately promoting better overall health and well-being for gastroesophageal reflux disease-affected individuals. For instance, in January 2023, according to the American Cancer Society, a US-based Professional organization, about 21,560 new esophageal cancer cases are diagnosed yearly in the United States, with 16,120 deaths from esophageal cancer. Therefore, the growing prevalence of esophageal diseases drives the growth of the gastroesophageal reflux disease (GERD) market.

Gastroesophageal Reflux Disease (GERD) Market Driver: Alcohol Consumption-Driven Expansion Of The Gastroesophageal Reflux Disease (GERD) Market

A high incidence of alcohol consumption is expected to propel the growth of the gastroesophageal reflux disease (GERD) market going forward. Alcohol consumption refers to the act of drinking a beverage containing ethanol, which is the only type of alcohol that is safe for human consumption. Alcohol use contributes to the development of GERD by decreasing esophageal motility and lowering pressure levels. For instance, according to the National Institute on Alcohol Abuse and Alcoholism, a US-based government agency, in 2021, the per capita consumption of ethanol from all alcoholic beverages in the United States reached 2.51 gallons, marking a 2.9% rise from 2.44 gallons in 2020. Hence, the elevated prevalence of alcohol consumption is propelling the expansion of the gastroesophageal reflux disease (GERD) market.

Global Gastroesophageal Reflux Disease (GERD) Market Major Players

Major players in the gastroesophageal reflux disease (gerd) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd.

Global Gastroesophageal Reflux Disease (GERD) Market Restraint: Decline In Drug Development For Gastroesophageal Reflux Disease (GERD) Market

The decline in drug development for gastroesophageal reflux disease (GERD), mostly due to the conversion of most proton pump inhibitor (PPI)'s to generic and over-the-counter compounds, which can act as a challenge and may restrain the market's growth during the forecast period. There are fewer new drugs being developed for GERD, which limits the options available for patients who do not respond well to existing treatments. For instance, in November 2021, as per the study in Frontiers in Medicine, a US-based peer-reviewed journal, highlights unmet needs in GERD, including rapid postprandial heartburn control, improved volume reflux and acid regurgitation relief, night time heartburn relief, acid control in BE patients, and a more flexible PPI administration schedule. The decline in drug development is predominantly due to the conversion of most PPIs to generic compounds. Therefore, the decline in drug development is hindering the growth of the gastroesophageal reflux disease (GERD) market.

Global Gastroesophageal Reflux Disease (GERD) Market Trend: Innovative Gerd Treatment Technologies Shape The Market

Major companies operating in the gastroesophageal reflux disease (GERD) market are focusing on introducing innovative gastroesophageal reflux disease treatment devices to sustain their position in the market. For instance, in April 2023, Laborie Medical Technologies, a US-based medical technology company, launched the new alpHaONE wireless pH-capsule reflux testing diagnostic system designed for diagnosing gastroesophageal reflux disease (GERD). The system provides up to 96 hours of monitoring data and offers a compact design with enlarged buttons and a fail-safe capsule delivery system. The system features a software application with a virtual instruction program and user-customizable symptom buttons for improved user experience.

Gastroesophageal Reflux Disease (GERD) Market Merger And Acquisition: Sebela Pharmaceuticals Expands Gastroesophageal Reflux Disease Portfolio Through Partnership With Hk Inno.N Corporation For Tegoprazan Development

In October 2022, Sebela Pharmaceuticals Inc., a US-based pharmaceutical company that manufactures gastroesophageal reflux disease drugs, partnered with HK Inno. N Corporation, a South Korea-based pharmaceutical company, for an undisclosed amount. With this partnership, both companies aim to develop and commercialize tegoprazan, a novel potassium-competitive acid blocker (P-CAB)in the US and Canada, already approved and marketed in South Korea and China. Additionally, Sebela Pharmaceuticals expands its gastroenterology portfolio with a new treatment option for people with gastroesophageal reflux disease.

Regional Outlook For The Global Gastroesophageal Reflux Disease (GERD) Market

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gastroesophageal reflux disease (GERD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastroesophageal reflux disease (GERD) market consists of revenues earned by entities by providing pharmaceutical therapies, surgical procedures and diagnostic tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastroesophageal reflux disease (GERD) market also includes sales of gamma-aminobutyric acid type B receptor agonists and alginate antacids. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The gastroesophageal reflux disease (GERD) market research report is one of a series of new reports from The Business Research Company that provides gastroesophageal reflux disease (GERD) market statistics, including gastroesophageal reflux disease (GERD) industry global market size, regional shares, competitors with a gastroesophageal reflux disease (GERD) market share, detailed gastroesophageal reflux disease (GERD) market segments, market trends and opportunities and any further data you may need to thrive in the gastroesophageal reflux disease (GERD) industry. This gastroesophageal reflux disease (GERD) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Gastroesophageal Reflux Disease (GERD) Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$5.25 billion
Revenue Forecast In 2033	$5.74 billion
Growth Rate	CAGR of 2.3% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF) 2) By Procedure: Invasive, Minimally Invasive 3) By End-Users: Hospital, Homecare, Specialty Clinics
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	GlaxoSmithKline PLC; SRS Life Sciences; Johnson & Johnson Services Inc.; Takeda Pharmaceutical Company Limited; AstraZeneca Plc; Reckitt Benckiser Group Plc; Eisai Co. Ltd.; Pfizer Inc.; Medtronic Plc; Teva Pharmaceuticals; HK inno.N Corporation; Sebela Pharmaceuticals; Mylan N.V.; Bausch Health Companies Inc.; Johnson & Johnson MedTech; Eisai Co. Ltd.; Sun Pharmaceutical Industries Ltd.; Perrigo Company PLC; Dr. Reddy's Laboratories Ltd.; Aurobindo Pharma Limited; Cipla Limited; Ferring B.V.; Amneal Pharmaceuticals LLC; Zydus Lifesciences Ltd.; Lupin Limited; Torrent Pharmaceuticals Ltd.; Salix Pharmaceuticals Inc.; Almirall S.A.; HK inno.N Corporation; SRS Life Sciences Pte. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Gastroesophageal Reflux Disease (GERD) Market Characteristics

3. Gastroesophageal Reflux Disease (GERD) Market Trends And Strategies

4. Gastroesophageal Reflux Disease (GERD) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Gastroesophageal Reflux Disease (GERD) Market Size and Growth

5.1. Global Gastroesophageal Reflux Disease (GERD) Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Gastroesophageal Reflux Disease (GERD) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Gastroesophageal Reflux Disease (GERD) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Gastroesophageal Reflux Disease (GERD) Market Segmentation

6.1. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Antacids

Proton Pump Inhibitors

H2 Receptor Blocker

Pro Kinetic Agents

Dopamine Receptor Antagonist

EndoCinch

Stretta

EsophyX

Transoral Incisionless Fundoplication (TIF)

6.2. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Invasive

Minimally Invasive

6.3. Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospital

Homecare

Specialty Clinics

7. Gastroesophageal Reflux Disease (GERD) Market Regional And Country Analysis

7.1. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market

8.1. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Gastroesophageal Reflux Disease (GERD) Market

9.1. China Gastroesophageal Reflux Disease (GERD) Market Overview

9.2. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Gastroesophageal Reflux Disease (GERD) Market

10.1. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Gastroesophageal Reflux Disease (GERD) Market

11.1. Japan Gastroesophageal Reflux Disease (GERD) Market Overview

11.2. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Gastroesophageal Reflux Disease (GERD) Market

12.1. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Gastroesophageal Reflux Disease (GERD) Market

13.1. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Gastroesophageal Reflux Disease (GERD) Market

14.1. South Korea Gastroesophageal Reflux Disease (GERD) Market Overview

14.2. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Gastroesophageal Reflux Disease (GERD) Market

15.1. Western Europe Gastroesophageal Reflux Disease (GERD) Market Overview

15.2. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Gastroesophageal Reflux Disease (GERD) Market

16.1. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Gastroesophageal Reflux Disease (GERD) Market

17.1. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Gastroesophageal Reflux Disease (GERD) Market

18.5. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Gastroesophageal Reflux Disease (GERD) Market

19.9. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Gastroesophageal Reflux Disease (GERD) Market

20.13. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market

21.1. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market Overview

21.2. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Gastroesophageal Reflux Disease (GERD) Market

22.1. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Gastroesophageal Reflux Disease (GERD) Market

23.1. North America Gastroesophageal Reflux Disease (GERD) Market Overview

23.2. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Gastroesophageal Reflux Disease (GERD) Market

24.1. USA Gastroesophageal Reflux Disease (GERD) Market Overview

24.2. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Gastroesophageal Reflux Disease (GERD) Market

25.1. Canada Gastroesophageal Reflux Disease (GERD) Market Overview

25.2. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Gastroesophageal Reflux Disease (GERD) Market

26.1. South America Gastroesophageal Reflux Disease (GERD) Market Overview

26.2. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Gastroesophageal Reflux Disease (GERD) Market

27.1. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Gastroesophageal Reflux Disease (GERD) Market

28.1. Middle East Gastroesophageal Reflux Disease (GERD) Market Overview

28.2. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Gastroesophageal Reflux Disease (GERD) Market

29.1. Africa Gastroesophageal Reflux Disease (GERD) Market Overview

29.2. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape And Company Profiles

30.1. Gastroesophageal Reflux Disease (GERD) Market Competitive Landscape

30.2. Gastroesophageal Reflux Disease (GERD) Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Merck and Co. Inc.

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. Novartis AG

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Abbott Laboratories

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. GlaxoSmithKline Plc

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Gastroesophageal Reflux Disease (GERD) Market Other Major And Innovative Companies

31.1. Medtronic Plc

31.2. Takeda Pharmaceutical Company Limited

31.3. Eli Lilly and Company

31.4. Amgen Inc.

31.5. Boehringer Ingelheim International GmbH

31.6. Reckitt Benckiser Group Plc

31.7. Teva Pharmaceutical Industries Ltd.

31.8. Mylan N.V.

31.9. Bausch Health Companies Inc.

31.10. Johnson & Johnson MedTech

31.11. Eisai Co. Ltd.

31.12. Sun Pharmaceutical Industries Ltd.

31.13. Perrigo Company PLC

31.14. Dr. Reddy's Laboratories Ltd.

31.15. Aurobindo Pharma Limited

32. Global Gastroesophageal Reflux Disease (GERD) Market Competitive Benchmarking

33. Global Gastroesophageal Reflux Disease (GERD) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Gastroesophageal Reflux Disease (GERD) Market

35. Gastroesophageal Reflux Disease (GERD) Market Future Outlook and Potential Analysis

35.1 Gastroesophageal Reflux Disease (GERD) Market In 2028 - Countries Offering Most New Opportunities

35.2 Gastroesophageal Reflux Disease (GERD) Market In 2028 - Segments Offering Most New Opportunities

35.3 Gastroesophageal Reflux Disease (GERD) Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: Merck and Co. Inc. Financial Performance

Table 76: Novartis AG Financial Performance

Table 77: Abbott Laboratories Financial Performance

Table 78: GlaxoSmithKline Plc Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Gastroesophageal Reflux Disease (GERD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By Procedure, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Gastroesophageal Reflux Disease (GERD) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: Merck and Co. Inc. Financial Performance

Figure 76: Novartis AG Financial Performance

Figure 77: Abbott Laboratories Financial Performance

Figure 78: GlaxoSmithKline Plc Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the video management system market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the single use bioprocessing market research report 2022 with industry size, share, segments and market growth

Inflammatory Bowel Disease Treatment Global Market Report 2024 – By Drug Class (Aminosalicylates, Corticosteroids, TNF inhibitors, IL inhibitors, Anti-integrin, JAK inhibitors, Other Drug Classes), By Type (Crohn's Disease, Ulcerative Colitis), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Irritable Bowel Syndrome (IBS) Treatment Global Market Report 2024 – By Drug Type (Lubiprostone, Linaclotide, Eluxadoline, Rifaximin, Alosetron, Other Drugs), By Indication (IBS With Constipation, IBS With Diarrhea, IBS With Alternating Constipation And Diarrhea), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), By End-Users (Hospitals, Clinics, Homecare Settings) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Cancer Drugs Global Market Report 2024 – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Specialty Centers) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Volvulus Treatment Global Market Report 2024 – By Type (Organo-Axial Volvulus, Mesentero-Axial Volvulus), By Treatment Type (Medication, Surgery), By Route of Administration (Oral, Parenteral), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy), By End-User (Hospitals, Homecare, Specialty Clinics, Other End-Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Gastric Cancer Diagnostic Procedure Global Market Report 2024 – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue tests, Lab tests, In-vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multiplexing Molecular Diagnostics, Immunoassays, Other Procedure Types ), By Symptom Type (Symptomatic, Asymptomatic), By Offering Type (Instruments, Reagents and Consumables, Services), By Body Fluid Type (Blood, Urine, Saliva, Stomach Juice, Tissue, Other Body Fluid), By Disease Indication (Early Gastric Cancer, Advanced Gastric Cancer) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Antacids Global Market Report 2024 – By Drug Class (Proton Pump Inhibitors, H2 Antagonist, Acid Neutralizers, Pro-Motility Agents), By Formulation Type (Tablet, Liquid, Powder, Other Formulation Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digestive Health Global Market Report 2024 – By Product Type (Functional Foods and Beverages, Vitamins and Dietary Supplements, Other Products), By Ingredient Type (Probiotics, Prebiotics, Digestive Enzymes, Other Ingredients), By Distribution Channel (Supermarkets/Hypermarkets, Hospital Pharmacies, Online Pharmacies, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digestive Health Supplements Global Market Report 2024 – By Product (Prebiotics, Probiotics, Enzymes, Fulvic Acid, Other Product), By Form (Capsules, Tablets, Powders, Liquids, Other Form), By Distribution Channel (Supermarkets/Hypermarkets, Convenience Store, Specialty Store, Pharmacies, E-Commerce, Other Distribution Channels) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the gastroesophageal reflux disease (GERD) market?

How will the gastroesophageal reflux disease (GERD) market drivers and restraints affect the gastroesophageal reflux disease (GERD) market dynamics? What forces will shape the gastroesophageal reflux disease (GERD) industry going forward?

The gastroesophageal reflux disease (GERD) market major growth driver - Rising Prevalence Of Esophageal Diseases Drives Growth In The Gastroesophageal Reflux Disease (GERD) Market. request a sample here

What is the forecast market size or the forecast market value of the gastroesophageal reflux disease (GERD) market?

The gastroesophageal reflux disease (GERD) market size has grown marginally in recent years. It will grow from $5.15 billion in 2023 to $5.25 billion in 2024 at a compound annual growth rate (CAGR) of 2.0%. The growth in the historic period can be attributed to lifestyle and dietary changes, obesity epidemic, growing awareness about gerd treatment, globalization of pharmaceutical industry, investments for gerd treatments. The gastroesophageal reflux disease (GERD) market size is expected to see steady growth in the next few years. It will grow to $5.74 billion in 2028 at a compound annual growth rate (CAGR) of 2.3%. The growth in the forecast period can be attributed to aging population, rising healthcare spending, emergence of biomarker, growing number of screening programs for gerd, increasing prevalence of heartburn, increased demand for medical equipment. Major trends in the forecast period include diagnostic advancements, surgical advancements, development of targeted therapies, adoption of telehealth services . request a sample here

How is the gastroesophageal reflux disease (GERD) market segmented?

The gastroesophageal reflux disease (GERD) market is segmented
1) By Drug Type: Antacids, Proton Pump Inhibitors, H2 Receptor Blocker, Pro Kinetic Agents, Dopamine Receptor Antagonist, EndoCinch, Stretta, EsophyX, Transoral Incisionless Fundoplication (TIF)
2) By Procedure: Invasive, Minimally Invasive
3) By End-Users: Hospital, Homecare, Specialty ClinicsFor further insights on the gastroesophageal reflux disease (GERD) market request a sample here

Which region has the largest share of the gastroesophageal reflux disease (GERD) market? What are the other regions covered in the report?

North America was the largest region in the gastroesophageal reflux disease (GERD) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gastroesophageal reflux disease (GERD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the gastroesophageal reflux disease (GERD) market?

Major players in the gastroesophageal reflux disease (GERD) market are GlaxoSmithKline PLC, SRS Life Sciences, Johnson & Johnson Services Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, Reckitt Benckiser Group PLC, Eisai Co. Ltd., Pfizer Inc., Medtronic PLC, Teva Pharmaceuticals, HK inno.N Corporation, Sebela Pharmaceuticals, Mylan N.V., Bausch Health Companies Inc., Johnson & Johnson MedTech, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Perrigo Company PLC, Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Limited, Cipla Limited, Ferring B.V., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd., Salix Pharmaceuticals Inc., Almirall S.A., HK inno.N Corporation, SRS Life Sciences Pte. Ltd. request a sample here.

What are the key trends in the gastroesophageal reflux disease (GERD) market?

Major trend in the gastroesophageal reflux disease (GERD) market - Innovative Gerd Treatment Technologies Shape The Market. request a sample here.

What are the major opportunities in the gastroesophageal reflux disease (GERD) market? What are the strategies for the gastroesophageal reflux disease (GERD) market?

For detailed insights on the major opportunities and strategies in the gastroesophageal reflux disease (GERD) market, request a sample here.

How does the gastroesophageal reflux disease (GERD) market relate to the overall economy and other similar markets?

For detailed insights on gastroesophageal reflux disease (GERD) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the gastroesophageal reflux disease (GERD) industry?

For detailed insights on the mergers and acquisitions in the gastroesophageal reflux disease (GERD) industry, request a sample here.

What are the key dynamics influencing the gastroesophageal reflux disease (GERD) market growth? SWOT analysis of the gastroesophageal reflux disease (GERD) market.

For detailed insights on the key dynamics influencing the gastroesophageal reflux disease (GERD) market growth and SWOT analysis of the gastroesophageal reflux disease (GERD) industry, request a sample here.